2019
Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study
Hruska CB, Hunt KN, Conners AL, Geske JR, Brandt KR, Degnim AC, Vachon CM, O’Connor M, Rhodes DJ. Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study. Breast Cancer Research 2019, 21: 38. PMID: 30850011, PMCID: PMC6408779, DOI: 10.1186/s13058-019-1120-5.Peer-Reviewed Original ResearchConceptsLow-dose tamoxifenMolecular breast imagingBackground parenchymal uptakeOral tamoxifenParenchymal uptakeBreast cancer risk reductionBreast cancer risk factorsEffectiveness of tamoxifenCancer risk factorsCancer risk reductionBreast cancer historyShort-term interventionMean ageCancer historyRisk factorsBreast fibroglandular tissueTamoxifenMolecular breastAverage countStudy participantsSubcutaneous fatPilot studyWomenT-testIntervention
2000
Breast cancer prevention trials
Rhodes D, Hartmann L, Perez E. Breast cancer prevention trials. Current Oncology Reports 2000, 2: 558-565. PMID: 11122893, DOI: 10.1007/s11912-000-0110-0.Peer-Reviewed Original ResearchConceptsBreast Cancer Prevention TrialCancer Prevention TrialBreast cancer incidenceBreast cancerPrevention trialsCancer incidenceBowel Project Breast Cancer Prevention TrialPrimary breast cancer preventionNational Surgical Adjuvant BreastEffectiveness of raloxifeneEfficacy of tamoxifenBreast cancer preventionHormone replacement therapyAdjuvant BreastPostmenopausal womenRandomized trialsReplacement therapyDrug therapyCancer preventionStudy populationEligibility criteriaChemopreventive agentsTamoxifenTreatment planRaloxifene